Price Moderation For Prescription Drugs Could Be Coming, Analysts Say.

reported that some analysts and investors believe the prospect of price moderation on prescription drugs could be coming due to structural changes in the marketplace caused by increased competition, government intervention, and backlash from pharmacy-benefit managers. According to the Journal, recent corporate earnings reports have called into question the ability of drugmakers to raise prices. Additional coverage is provided by Fierce Pharma (10/28, Staton). http://www.fiercepharma.com/pharma/amgen-bids-farewell-to-enbrel-price-hikes-and-big-sales-boosts-they-brought